Dennis A. Hesselink

11.5k total citations · 1 hit paper
262 papers, 6.9k citations indexed

About

Dennis A. Hesselink is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Dennis A. Hesselink has authored 262 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Transplantation, 83 papers in Pediatrics, Perinatology and Child Health and 72 papers in Surgery. Recurrent topics in Dennis A. Hesselink's work include Renal Transplantation Outcomes and Treatments (178 papers), Pharmacological Effects and Toxicity Studies (82 papers) and Organ Transplantation Techniques and Outcomes (43 papers). Dennis A. Hesselink is often cited by papers focused on Renal Transplantation Outcomes and Treatments (178 papers), Pharmacological Effects and Toxicity Studies (82 papers) and Organ Transplantation Techniques and Outcomes (43 papers). Dennis A. Hesselink collaborates with scholars based in Netherlands, United States and Belgium. Dennis A. Hesselink's co-authors include Teun van Gelder, Carla C. Baan, Laure Elens, Ron H. N. van Schaik, Rachida Bouamar, Ron HN van Schaik, Nauras Shuker, Brenda C. M. de Winter, Vincent Haufroid and Willem Weimar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Dennis A. Hesselink

250 papers receiving 6.9k citations

Hit Papers

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 ge... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis A. Hesselink Netherlands 43 4.3k 2.4k 1.8k 1.1k 1.0k 262 6.9k
Maarten Naesens Belgium 55 5.1k 1.2× 1.3k 0.5× 3.0k 1.7× 972 0.9× 595 0.6× 242 9.0k
Dany Anglicheau France 47 4.3k 1.0× 1.1k 0.5× 2.4k 1.4× 1.0k 0.9× 518 0.5× 213 7.9k
Christine E. Staatz Australia 35 3.2k 0.7× 1.9k 0.8× 1.0k 0.6× 711 0.6× 912 0.9× 124 5.2k
Johan W. de Fijter Netherlands 57 5.2k 1.2× 1.3k 0.6× 3.4k 1.9× 1.4k 1.2× 792 0.8× 323 11.1k
Michel Mourad Belgium 33 2.2k 0.5× 1.3k 0.6× 1.3k 0.7× 668 0.6× 470 0.5× 130 3.7k
Maria Shipkova Germany 40 3.2k 0.7× 1.0k 0.4× 760 0.4× 407 0.4× 603 0.6× 123 5.0k
Rita R. Alloway United States 44 3.9k 0.9× 933 0.4× 2.3k 1.3× 1.4k 1.2× 361 0.4× 227 6.2k
Hélio Tedesco‐Silva Brazil 35 4.5k 1.0× 848 0.4× 2.2k 1.2× 921 0.8× 558 0.6× 273 6.4k
Roslyn B. Mannon United States 45 3.9k 0.9× 546 0.2× 2.5k 1.4× 894 0.8× 663 0.7× 205 7.6k
Josep M. Grinyó Spain 57 7.3k 1.7× 1.2k 0.5× 4.1k 2.3× 1.1k 1.0× 715 0.7× 285 11.7k

Countries citing papers authored by Dennis A. Hesselink

Since Specialization
Citations

This map shows the geographic impact of Dennis A. Hesselink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis A. Hesselink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis A. Hesselink more than expected).

Fields of papers citing papers by Dennis A. Hesselink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis A. Hesselink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis A. Hesselink. The network helps show where Dennis A. Hesselink may publish in the future.

Co-authorship network of co-authors of Dennis A. Hesselink

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis A. Hesselink. A scholar is included among the top collaborators of Dennis A. Hesselink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis A. Hesselink. Dennis A. Hesselink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boer, Karin, et al.. (2025). Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression. BioDrugs. 39(3). 445–459. 2 indexed citations
2.
Hesselink, Dennis A., et al.. (2024). Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults. British Journal of Clinical Pharmacology. 91(6). 1551–1559. 1 indexed citations
3.
Dieterich, M., Sebastiaan Heidt, Eric M. Bindels, et al.. (2024). Tissue-resident memory T cells in human kidney transplants have alloreactive potential. American Journal of Transplantation. 24(8). 1406–1413.
4.
Groningen, Marian C. Clahsen‐van, Brenda C. M. de Winter, Priya Vart, et al.. (2024). Multicenter, Real‐World Clinical Evaluation of Alemtuzumab and Anti‐Thymocyte Globulin for Severe Acute T Cell‐Mediated Kidney Transplant Rejection. Clinical Transplantation. 38(12). e70046–e70046.
5.
Pengel, Liset, et al.. (2024). Removing the physician from the equation: Patient‐controlled, home‐based therapeutic drug self‐monitoring of tacrolimus. British Journal of Clinical Pharmacology. 91(6). 1560–1568. 4 indexed citations
6.
Hoek, Bart van, Ian P.J. Alwayn, Brenda C. M. de Winter, et al.. (2024). Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus: A Multicenter, Randomized Controlled Trial. Transplantation Direct. 10(4). e1612–e1612. 1 indexed citations
7.
Baan, Carla C., Dennis A. Hesselink, Jean–Paul Duong Van Huyen, et al.. (2023). Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity. Transplantation Direct. 9(5). e1480–e1480. 1 indexed citations
8.
Wetering, Jacqueline van de, Sam Schoenmakers, Maja Matić, et al.. (2023). Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study. British Journal of Clinical Pharmacology. 90(1). 176–188. 4 indexed citations
9.
Budde, Ricardo P.J., Dennis A. Hesselink, Felix Zijlstra, et al.. (2023). The prevalence of osteopenia and osteoporosis after heart transplantation assessed using CT. Clinical Radiology. 78(10). 772–778.
10.
Bosch, Thierry P. P. van den, Carla C. Baan, Dennis A. Hesselink, et al.. (2023). Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass. Kidney International. 105(4). 812–823. 16 indexed citations
11.
Udomkarnjananun, Suwasin, et al.. (2023). Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?. British Journal of Clinical Pharmacology. 91(6). 1530–1541. 10 indexed citations
12.
Lemaı̂tre, F., Klemens Budde, Teun van Gelder, et al.. (2022). Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19. Therapeutic Drug Monitoring. 45(2). 191–199. 35 indexed citations
13.
Uffing, Audrey, Dennis A. Hesselink, Juliana Mansur, et al.. (2022). Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation. Kidney International Reports. 7(6). 1424–1427. 6 indexed citations
14.
Elens, Laure, Loralie J. Langman, Dennis A. Hesselink, et al.. (2020). Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions. Therapeutic Drug Monitoring. 42(3). 360–368. 43 indexed citations
15.
Dulfer, R. R., Willemijn Y. van der Plas, Anton F. Engelsman, et al.. (2019). Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbeck s Archives of Surgery. 404(1). 71–79. 20 indexed citations
16.
Burgh, Anna C. van der, Brenda C.T. Kieboom, Teun van Gelder, et al.. (2019). Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study. Nephrology Dialysis Transplantation. 35(1). 176–183. 7 indexed citations
17.
Muslem, Rahatullah, Kadir Çalişkan, Şakir Akın, et al.. (2017). Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. The American Journal of Cardiology. 120(12). 2221–2225. 15 indexed citations
18.
Graav, Gretchen N. de, Stein Bergan, Carla C. Baan, et al.. (2014). Therapeutic Drug Monitoring of Belatacept in Kidney Transplantation. Therapeutic Drug Monitoring. 37(5). 560–567. 22 indexed citations
19.
Bouamar, Rachida, Dennis A. Hesselink, Ron H. N. van Schaik, et al.. (2011). Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation. Therapeutic Drug Monitoring. 33(2). 178–184. 35 indexed citations
20.
Hesselink, Dennis A., Reinier M. van Hest, Ron A. A. Mathôt, et al.. (2005). Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2. American Journal of Transplantation. 5(5). 987–994. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026